Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Clinical Characteristics and Prognostic Implication for Myelodysplastic Syndromes/Neoplasms Patients with or without Cytogenetic Abnormalities or Gene Mutations

Wan Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Shan-Chi Yu, Ming-Chih Liu, Chang-Tsu Yuan, Hwei-Fang Tien, Hsin-An Hou, Wen-Chien Chou

Blood (2024) 144 (Supplement 1): 6752.

https://doi.org/10.1182/blood-2024-211540

Published: 2024

Journal Articles

Clinical Characteristics and Prognostic Significance of PWWP2B Expression in AML Patients Treated with Intensive Chemotherapy

Cheng-Yeh Chen, Xavier Cheng-Hong Tsai, Kuojui Sun, Feng-Ming Tien, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Bor-Sheng Ko, Ming-Chih Liu, Chia-Wen Liu, Chien-Chin Lin, Ming Yao, Wen-Chien Chou, Hwei-Fang Tien, Hsin-An Hou

Blood (2024) 144 (Supplement 1): 6149.

https://doi.org/10.1182/blood-2024-209914

Published: 2024

Journal Articles

Clinical Features and Prognostic Implications of BCMA , BAFF , and APRIL Expression in Acute Myeloid Leukemia

Yun-Tzu Lin, Xavier Cheng-Hong Tsai, Kuojui Sun, Min Yen Lo, Feng-Ming Tien, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Ming-Chih Liu, Chia-Wen Liu, Chien-Chin Lin, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien

Blood (2024) 144 (Supplement 1): 6159.

https://doi.org/10.1182/blood-2024-211928

Published: 2024

Journal Articles

Clinico-Genetic and Prognostic Analyses of 635 Patients with Myelodysplastic Neoplasms Based on the 2022 World Health Organization Classification

Hsin-Yu Lu, Wan Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Shan-Chi Yu, Ming-Chih Liu, Chang-Tsu Yuan, Yi-Tsung Yang, Ming-Kai Chuang, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Hsin-An Hou, Hwei-Fang Tien, Wen-Chien Chou

Blood (2023) 142 (Supplement 1): 1878.

https://doi.org/10.1182/blood-2023-186106

Published: 2023

Journal Articles

Prognostic Relevance of Adult Acute Myeloid Leukemia Patients According to the 2022 European Leukemianet Risk Stratiﬁcation

Min Yen Lo, Cheng-Hong Tsai, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Cheng-An Hsu, Hsun-I Sun, Yi-Kuang Chuang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien

Blood (2022) 140 (Supplement 1): 130–131.

https://doi.org/10.1182/blood-2022-168522

Published: 2022

Journal Articles

Effect of Mutation Allele Frequency on the Risk Stratification of Myelodysplastic Syndrome Patients

Wan Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming-Chih Liu, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien

Blood (2022) 140 (Supplement 1): 6932–6933.

https://doi.org/10.1182/blood-2022-159872

Published: 2022

Journal Articles

Minimal Residual Disease Monitoring By Next-Generation Sequencing in Patients with Acute Myeloid Leukemia: MRD Positivity after First Consolidation Chemotherapy Can Better Predict Clinical Outcomes Than That after Induction Chemotherapy

Cheng-Hong Tsai, MD MSc, Jih-Luh Tang, MD, PhD, Feng-Ming Tien, MD, M.Sc, Yuan-Yeh Kuo, PhD, Chien-Chin Lin, MD, Mei-Hsuan Tseng, M.Sc., Yen-Ling Peng, M.Sc., Ming-Chih Liu, Chia-Wen Liu, Ming Yao, Liang-In Lin, PhD, Wen-Chien Chou, MD, PhD, Chien-Yu Chen, PhD, Hsin-An Hou, Hwei-Fang Tien, MD, PhD

Blood (2019) 134 (Supplement_1): 2698.

https://doi.org/10.1182/blood-2019-126870

Published: 2019

Journal Articles

The Clinical Association and Prognostic Impact of IL1RAP Expression in Patients with De Novo Acute Myeloid Leukemia

Chao-Hung Wei, MD, Cheng-Hong Tsai, MD, M.Sc., Jih-Luh Tang, MD, PhD, Yuan-Yeh Kuo, PhD, Feng-Ming Tien, MD, M.Sc, Chien-Chin Lin, MD, Mei-Hsuan Tseng, M.Sc., Yen-Ling Peng, Ming-Chih Liu, Chia-Wen Liu, Ming Yao, MD, Liang-In Lin, PhD, Wen-Chien Chou, MD, PhD, Chien-Yu Chen, PhD, Hsin-An Hou, Hwei-Fang Tien, MD, PhD

Blood (2019) 134 (Supplement_1): 2705.

https://doi.org/10.1182/blood-2019-124657

Published: 2019

Journal Articles

Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novo aml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3 -ITD Patients

Blood (2018) 132 (Supplement 1): 3977.

https://doi.org/10.1182/blood-2018-99-114315

Published: 2018

Journal Articles

Discrepant Mutational Composition between Myeloid Sarcoma and Bone Marrow Leukemia Revealed through Targeted Next Generation Sequencing

Sze Hwei Lee, MD, Tai-Chung Huang, MD PhD, Yuan Chang-Tsu, MD, Yuan-Yeh Kuo, PhD, Rung-Jing Chiou, Yi-Kuang Chuang, Hwei-Fang Tien, MD, PhD, Jih-Luh Tang, MD

Blood (2018) 132 (Supplement 1): 1395.

https://doi.org/10.1182/blood-2018-99-116637

Published: 2018

Journal Articles

Botanical Alkyl Hydroquinone Derivative HQ17(3) Induces Calcium-Associated Mitochondrial Damage and Mitophagy to Exert Ctotoxicity to Philadelphila Chromosome(+) ALL Cells

Yin-Chen Chou, MS, Chia-Wei Chen, MS, Yuan-Yeh Kuo, PhD, Liang-In Lin, PhD, Chung-Yi Hu, PhD

Blood (2018) 132 (Supplement 1): 5800.

https://doi.org/10.1182/blood-2018-99-120307

Published: 2018

Journal Articles

The Clinical Implication and Prognostic Impact of Dynamic Molecular Evolution in Acute Myeloid Leukemia

Jui-Che Chen, MD, Cheng-Hong Tsai, MD, M.Sc., Jih-Luh Tang, MD,PhD, Yuan-Yeh Kuo, PhD, Chien-Chin Lin, MD, Mei-Hsuan Tseng, M.Sc., Ming Yao, MD, Chi-Cheng Li, MD, Shang-Yi Huang, MD, PhD, Bor-Sheng Ko, MD, PhD, Szu-Chun Hsu, MD, Chien-Ting Lin, MD, Shang-Ju Wu, MD, PhD, Chien-Yuan Chen, MD, PhD, Woei Tsai, MD, PhD, Wen-Chien Chou, MD, PhD, Hsin-An Hou, MD, PhD, Hwei-Fang Tien, MD, PhD

Blood (2017) 130 (Supplement 1): 1300.

https://doi.org/10.1182/blood.V130.Suppl_1.1300.1300

Published: 2017

Journal Articles

Prognostic Impacts and Dynamic Changes of Cohesin Complex Gene Mutations in De Novo Acute Myeloid Leukemia

Cheng-Hong Tsai, MD, M.Sc., Hsin-An Hou, MD, PhD, Jih-Luh Tang, MD,PhD, Yuan-Yeh Kuo, PhD, Yu-Chiao Chiu, PhD, Chien-Chin Lin, MD, Liang-In Lin, PhD, Ming Yao, MD, Chi-Cheng Li, MD, Shang-Yi Huang, MD, PhD, Bor-Sheng Ko, MD, PhD, Szu Chun Hsu, MD, Chien-Ting Lin, MD, Shang-Ju Wu, MD, PhD, Chien-Yuan Chen, MD, PhD, Woei Tsai, MD, PhD, Wen-Chien Chou, MD, PhD, Hwei-Fang Tien, MD, PhD

Blood (2017) 130 (Supplement 1): 2582.

https://doi.org/10.1182/blood.V130.Suppl_1.2582.2582

Published: 2017

Journal Articles

Overexpression of Calr Mutants Perturbs Developmental Hematopoiesis in Zebrafish Embryos

Ken-Hong Lim, MD, Yu-Cheng Chang, MD, Yi-Hao Chiang, MD, Huan-Chau Lin, MD, Chiao-Yi Chang, MSc, Ching-Sung Lin, MSc, Ling Huang, MSc, Wei-Ting Wang, MSc, Caleb Gon-Shen Chen, MD PhD, Wen-Chien Chou, MD PhD, Yuan-Yeh Kuo, PhD

Blood (2016) 128 (22): 4282.

https://doi.org/10.1182/blood.V128.22.4282.4282

Published: 2016

Journal Articles

B Cell Immune Profiles in Essential Thrombocythemia with Calr Mutations: Clinical and Molecular Correlates

Yu-Cheng Chang, MD, Ken-Hong Lim, MD, Huan-Chau Lin, MD, Yi-Hao Chiang, MD, Ling Huang, MSc, Chen-Wei Kao, Chiao-Yi Chang, MSc, Ching-Sung Lin, MSc, Nai-Wen Su, MD, Johnson Lin, MD MPH, Ruey-Kuen Hsieh, MD, Ming-Chih Chang, MD, Yi-Fang Chang, MD PhD, Caleb Gon-Shen Chen, MD PhD, Yuan-Yeh Kuo, PhD, Wen-Chien Chou, MD PhD

Blood (2015) 126 (23): 1610.

https://doi.org/10.1182/blood.V126.23.1610.1610

Published: 2015

Journal Articles

Calr Mutations in Essential Thrombocythemia: Frequency, Clinical Correlation and Screening By High-Resolution Melting Analysis

Ken-Hong Lim, MD, Huan-Chau Lin, MD, Yi-Hao Chiang, MD, Wei-Ting Wang, MSc, Ching-Sung Lin, MSc, Yu-Cheng Chang, MD, Nai-Wen Su, MD, Caleb Gon-Shen Chen, MD PhD, Johnson Lin, MD, Ruey-Kuen Hsieh, MD, Ming-Chih Chang, MD, Yi-Fang Chang, MD, Yuan-Yeh Kuo, PhD, Wen-Chien Chou, MD PhD

Blood (2014) 124 (21): 1838.

https://doi.org/10.1182/blood.V124.21.1838.1838

Published: 2014

Journal Articles

Higher Expression of Suppressor of Cytokine Signaling1 ( SOCS1 ) in the Bone Marrow Is an Unfavorable Prognostic Factor in Adult Patients with De Novo Acute Myeloid Leukemia

Cheng-Hong Tsai, MD, Hwei-Fang Tien, MD PhD, Hsin-An Hou, MD PhD, Wen-Chien Chou, MD PhD, Yan-Jun Lai, Yuan-Yeh Kuo, PhD, Chien-Yuan Chen, MD PhD, Jih-Luh Tang, MD PhD, Ming Yao, MD, Shang-Yi Huang, Bor-Sheng Ko, MD PhD, Szu-Chun Hsu, MD, Shang-Ju Wu, MD PhD, Woei Tsay, MD PhD, Yao-Chang Chen, MDPhD, Mei-Hsuan Tseng, Chi-Fei Huang

Blood (2014) 124 (21): 1034.

https://doi.org/10.1182/blood.V124.21.1034.1034

Published: 2014

Journal Articles

The Role Of tet2 DNA Methylcytosine Dioxygenase In Zebrafish Early Hematopoiesis

Huan-Chau Lin, MD, Ken-Hong Lim, MD, Yi-Hao Chiang, MD, Wei-Ting Wang, MSc, Ching-Sung Lin, MSc, Yu-Cheng Chang, MD, Ruey-Kuen Hsieh, MD, Yuan-Yeh Kuo, PhD, Wen-Chien Chou, MD, PhD

Blood (2013) 122 (21): 1204.

https://doi.org/10.1182/blood.V122.21.1204.1204

Published: 2013

Journal Articles

DNMT3A mutations in De Novo Myelodysplastic Syndrome: Distinct Clinico-Biological Features and Prognostic Relevance

Blood (2012) 120 (21): 3799.

https://doi.org/10.1182/blood.V120.21.3799.3799

Published: 2012

Journal Articles

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution

Shang-Ju Wu, Yuan-Yeh Kuo, Hsin-An Hou, Li-Yu Li, Mei-Hsuan Tseng, Chi-Fei Huang, Fen-Yu Lee, Ming-Chih Liu, Chia-Wen Liu, Chien-Ting Lin, Chien-Yuan Chen, Wen-Chien Chou, Ming Yao, Shang-Yi Huang, Bor-Sheng Ko, Jih-Luh Tang, Woei Tsay, Hwei-Fang Tien

Blood (2012) 120 (15): 3106–3111.

https://doi.org/10.1182/blood-2012-02-412296

Published: 2012

Includes: Supplemental data

NARROW

Clinical Characteristics and Prognostic Implication for Myelodysplastic Syndromes/Neoplasms Patients with or without Cytogenetic Abnormalities or Gene Mutations

Clinical Characteristics and Prognostic Significance of PWWP2B Expression in AML Patients Treated with Intensive Chemotherapy

Clinical Features and Prognostic Implications of BCMA , BAFF , and APRIL Expression in Acute Myeloid Leukemia

Clinico-Genetic and Prognostic Analyses of 635 Patients with Myelodysplastic Neoplasms Based on the 2022 World Health Organization Classification

Prognostic Relevance of Adult Acute Myeloid Leukemia Patients According to the 2022 European Leukemianet Risk Stratiﬁcation

Effect of Mutation Allele Frequency on the Risk Stratification of Myelodysplastic Syndrome Patients

Minimal Residual Disease Monitoring By Next-Generation Sequencing in Patients with Acute Myeloid Leukemia: MRD Positivity after First Consolidation Chemotherapy Can Better Predict Clinical Outcomes Than That after Induction Chemotherapy

The Clinical Association and Prognostic Impact of IL1RAP Expression in Patients with De Novo Acute Myeloid Leukemia

Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novo aml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3 -ITD Patients

Discrepant Mutational Composition between Myeloid Sarcoma and Bone Marrow Leukemia Revealed through Targeted Next Generation Sequencing

Botanical Alkyl Hydroquinone Derivative HQ17(3) Induces Calcium-Associated Mitochondrial Damage and Mitophagy to Exert Ctotoxicity to Philadelphila Chromosome(+) ALL Cells

The Clinical Implication and Prognostic Impact of Dynamic Molecular Evolution in Acute Myeloid Leukemia

Prognostic Impacts and Dynamic Changes of Cohesin Complex Gene Mutations in De Novo Acute Myeloid Leukemia

Overexpression of Calr Mutants Perturbs Developmental Hematopoiesis in Zebrafish Embryos

B Cell Immune Profiles in Essential Thrombocythemia with Calr Mutations: Clinical and Molecular Correlates

Calr Mutations in Essential Thrombocythemia: Frequency, Clinical Correlation and Screening By High-Resolution Melting Analysis

Higher Expression of Suppressor of Cytokine Signaling1 ( SOCS1 ) in the Bone Marrow Is an Unfavorable Prognostic Factor in Adult Patients with De Novo Acute Myeloid Leukemia

The Role Of tet2 DNA Methylcytosine Dioxygenase In Zebrafish Early Hematopoiesis

DNMT3A mutations in De Novo Myelodysplastic Syndrome: Distinct Clinico-Biological Features and Prognostic Relevance

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only